ERIC President James Gelfand Testifies Before Congress on Improving Affordability of Prescription Drugs

Washington, D.C., February 11, 2026– Today, James Gelfand, President and CEO of The ERISA Industry Committee (ERIC), testified before the U.S. House of Representatives Energy and Commerce Committee’s Subcommittee on Health at a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain.” The hearing focused on the root drivers of prescription drug costs and ways to keep them both accessible and affordable.

ERIC Files Amicus Brief to Stop Abuse of No Surprises Act Arbitration Process

Washington, D.C., February 9, 2026– On Friday, The ERISA Industry Committee (ERIC) filed an amicus brief with the U.S. District Court for the Central District of California in Anthem Blue Cross Life and Health Insurance Company v. HaloMD LLC (Anthem). The brief urges the Court to allow the plaintiff’s case to proceed by rejecting the defendant’s motion to dismiss.

ERIC Urges Maryland Lawmakers to Reconsider Adoption of the Biden Administration’s Suspended, Contested Mental Health Parity Rules

Washington, D.C., January 30, 2026 – The ERISA Industry Committee (ERIC) submitted public comments this week to Maryland House and Senate lawmakers, warning against proposed legislation (HB 280 and SB 205) that would prematurely codify in state law the former Administration’s federal mental health parity rules that are currently suspended from enforcement as litigation is pending challenging their validity under federal law and the U.S. Constitution.

ERIC Applauds Introduction of the PBM Fiduciary Accountability, Integrity, and Reform (FAIR) Act

Washington, D.C., December 19, 2025– The ERISA Industry Committee (“ERIC”) today applauded the introduction of the PBM Fiduciary Accountability, Integrity, and Reform (FAIR) Act. The legislation, introduced by Representatives Auchincloss (D-MA) and Mackenzie (R-PA), and Senators Marshall (R-KS), Kaine (D-VA), Grassley (R-IA) and Hassan (D-NH), clarifies that fiduciary standards for employer health benefit plans governed by the Employee Income and Retirement Security Act (ERISA) apply in full to pharmacy benefit managers (PBMs) performing services on behalf of the plan.